Arbutus Biopharma Corporation company logo
Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation (ABUS) EBITDA

Annual EBITDA

-$68.59M$8.04M+10.49%

Summary

Current Value
As of today, ABUS annual EBITDA is -$68.59M, up +10.49% on
Historical Performance
ABUS annual EBITDA is up +1.86% over the past 3 years, and up +1.04% over the past 5 years
All-Time High Comparison
ABUS annual EBITDA is currently -1384.27% below its historical high of $5.34M set on
3-Year Low Comparison
ABUS annual EBITDA is +10.49% above its 3-year low of -$76.63M reached on
Sector Comparison
ABUS annual EBITDA is higher than 23.01% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ABUS Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA-$68.59M+10.5%+1.9%+1.0%-944.7%
Quarterly EBITDA-$8.28M+51.7%+52.0%+43.3%-334.2%
TTM EBITDA-$30.67M+60.2%+50.0%+41.3%-442.3%
Price$4.50+34.3%+57.9%+11.4%-24.0%
PE Ratio-
Annual Revenue$6.17M-66.0%-43.8%+2.7%-51.2%
Annual EPS-$0.38+14.2%+54.7%+87.0%-126.1%
-$69.97M+10.3%+2.3%+1.9%-740.7%
Annual Net Income-$69.92M+4.0%+8.3%+54.5%-716.6%

EBITDA Highs

ABUS Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$61.80MN/A-11.0%
5Y-$55.29MN/A-24.1%
All$5.34M-1384.3%

EBITDA Lows

ABUS Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$76.63M+10.5%
5Y-$76.63M+10.5%
All-$76.63M+10.5%

EBITDA History

YearValueChange
-$68.59M+10.5%
-$76.63M-24.0%
-$61.80M+11.6%
-$69.90M-26.4%
-$55.29M+20.2%
-$69.32M-1.9%
-$68.01M+0.1%
-$68.11M-1.3%
-$67.20M-84.8%
-$36.37M-12.1%
-$32.44M-181.1%
-$11.54M+4.3%
-$12.06M-25.3%
-$9.63M-78.4%
YearValueChange
-$5.40M+17.8%
-$6.57M+20.3%
-$8.24M-392.8%
$2.81M-47.3%
$5.34M+840.5%
$567.90K+103.4%
-$16.82M+34.6%
-$25.71M-16.2%
-$22.12M-72.3%
-$12.84M-31.6%
-$9.76M-34.9%
-$7.23M+17.4%
-$8.75M-28.1%
-$6.83M-

FAQ

  • What is the current annual EBITDA of ABUS?

    As of today, ABUS annual EBITDA is -$68.59M

  • What is 1-year change in ABUS annual EBITDA?

    ABUS annual EBITDA is up +10.49% year-over-year

  • What is 3-year change in ABUS annual EBITDA?

    ABUS annual EBITDA is up +1.86% over the past 3 years

  • How far is ABUS annual EBITDA from its all-time high?

    ABUS annual EBITDA is currently -1384.27% below its historical high of $5.34M set on December 31, 2006

  • How does ABUS annual EBITDA rank versus sector peers?

    ABUS annual EBITDA is higher than 23.01% of companies in Healthcare sector

  • When is ABUS next annual earnings release?

    The next annual earnings release for ABUS is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. ABUS Official Website www.arbutusbio.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1447028/000144702825000126/0001447028-25-000126-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1447028/000144702825000083/0001447028-25-000083-index.htm
  4. ABUS Profile on Yahoo Finance finance.yahoo.com/quote/ABUS
  5. ABUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abus